This webinar is the third in a CTTI-hosted series designed to provide real-world examples of applying QbD to clinical trials. Click here for more information about CTTI's QbD Project.
*The views and opinions expressed in this video are those of the speaker and do not necessarily reflect the official policy or position of CTTI.
Webinar Agenda
Introduction to CTTI by Pamela Tenaerts, Executive Director, CTTI
Upcoming CTTI QbD Project Activities by Ann Meeker O’Connell
QbD Implementation by Louise Bowman
Implementation of QbD in Clinical Trials: Panel Discussion by:
Ann Meeker-O’Connell, Head, Risk Management and External Engagement, Janssen
Coleen Glessner, Vice President, Clinical Trial Process and Quality, Pfizer
Sabrina Comic-Savic, Senior Director, GCP Compliance, The Medicines Company